Search research articles
Contact Us
Filters
Showing results (71-80 of 141) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial
Lajos Pusztai, Jong-Hyeon Jeong, Yun Gong, et al.
ESMO Open
|
September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2011
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers
Charles Coutant, Roman Rouzier, Yuan Qi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 18, 2025
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial
Frédérique Penault-Llorca, Amelie Lusque, Thomas Filleron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2014
Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer
Kathy D Miller, Véronique Diéras, Nadia Harbeck, et al.
Cancer Letters
|
November 11, 2025
Single-cell transcriptome profiling of post-treatment and treatment-naïve colorectal cancer: Insights into putative mechanisms of chemoresistance
Grigory A Puzanov, Clémence Astier, Dimitris Papakonstantinou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2021
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study
Giuseppe Curigliano, Miguel Martin, Komal Jhaveri, et al.
Breast (Edinburgh, Scotland)
|
September 25, 2012
Gene copy number variations in breast cancer of Sub-Saharan African women
Madani Ly, Alexander Valent, Gangaly Diallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2009
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array
Fabrice Andre, Bastien Job, Philippe Dessen, et al.
Lancet (London, England)
|
July 31, 2002
Malignant effusions and immunogenic tumour-derived exosomes
Fabrice Andre, Noel E C Schartz, Mojgan Movassagh, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 141) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial
Lajos Pusztai, Jong-Hyeon Jeong, Yun Gong, et al.
ESMO Open
|
September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2011
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers
Charles Coutant, Roman Rouzier, Yuan Qi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 18, 2025
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial
Frédérique Penault-Llorca, Amelie Lusque, Thomas Filleron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2014
Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer
Kathy D Miller, Véronique Diéras, Nadia Harbeck, et al.
Cancer Letters
|
November 11, 2025
Single-cell transcriptome profiling of post-treatment and treatment-naïve colorectal cancer: Insights into putative mechanisms of chemoresistance
Grigory A Puzanov, Clémence Astier, Dimitris Papakonstantinou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2021
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study
Giuseppe Curigliano, Miguel Martin, Komal Jhaveri, et al.
Breast (Edinburgh, Scotland)
|
September 25, 2012
Gene copy number variations in breast cancer of Sub-Saharan African women
Madani Ly, Alexander Valent, Gangaly Diallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2009
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array
Fabrice Andre, Bastien Job, Philippe Dessen, et al.
Lancet (London, England)
|
July 31, 2002
Malignant effusions and immunogenic tumour-derived exosomes
Fabrice Andre, Noel E C Schartz, Mojgan Movassagh, et al.
Page
of 15